Mixture of MMP-2, MLC, and NOS Inhibitors Affects NO Metabolism and Protects Heart from Cardiac I/R Injury.

Conclusions: Synergistic effect of the multidrug therapy with the subthreshold doses allows addressing a few pathways of I/R injury simultaneously to achieve protection of cardiac function during I/R. PMID: 32322413 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/32322413?dopt=Abstract

Source: Cardiology Research and Practice - April 25, 2020 Category: Cardiology Authors: Krzywonos-Zawadzka A, Franczak A, Sawicki G, Bil-Lula I Tags: Cardiol Res Pract Source Type: research